Neoadjuvant docetaxel and capecitabine in patients with high risk/locally advanced prostate cancer: Preliminary results of a phase II study.

被引：0
|
作者：
Friedman, JD
Vaishampayan, U
Montie, J
Shah, R
Sarkar, F
Smith, D
Hussain, M
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：438S / 438S
页数：1
相关论文
共 50 条
  • [41] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    ANGIOGENESIS, 2012, 15 (01) : 141 - 150
  • [42] Neoadjuvant capecitabine (X), docetaxel (T) ± trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC):: preliminary safety and efficacy data from a multicentre phase II study
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 157 - 158
  • [43] Multicenter phase II study of neoadjuvant capecitabine (X), docetaxel (T) ±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC):: Preliminary safety and efficacy data.
    Lybaert, W.
    Wildiers, H.
    Neven, P.
    Clement, P.
    Amant, F.
    Christiaens, M-R
    Smeets, A.
    Van Limbergen, E.
    Weltens, C.
    Drijkoningen, R.
    Debrock, G.
    Paridaens, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S147 - S148
  • [44] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    Delrio, P
    Avallone, A
    Guida, C
    Marone, P
    Petrillo, A
    Tatangelo, F
    Di Marzo, M
    Scala, D
    Parisi, V
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S115 - S115
  • [45] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    P. Delrio
    A. Avallone
    C. Guida
    P. Marone
    A. Petrillo
    F. Tatangelo
    M. Di Marzo
    D. Scala
    V. Parisi
    Annals of Surgical Oncology, 2004, 11 : S115 - S115
  • [46] A phase I/II study of imatinib and docetaxel as neoadjuvant therapy in locally advanced breast cancer
    Haley, B. B.
    Ashfaq, R.
    DeHaas, M.
    Ramaswami, A.
    Sikder, K.
    Tripathy, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
    Yu, Deguo
    Wang, Zhenfeng
    He, Tingbang
    Yang, Lijun
    FRONTIERS IN SURGERY, 2022, 9
  • [48] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Park, YH
    Ryoo, BY
    Choi, SJ
    Kim, HT
    BRITISH JOURNAL OF CANCER, 2004, 90 (07) : 1329 - 1333
  • [49] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Y H Park
    B-Y Ryoo
    S-J Choi
    H-T Kim
    British Journal of Cancer, 2004, 90 : 1329 - 1333
  • [50] Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
    Sym, Sun Jin
    Chang, Heung Moon
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Kim, Tae Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (04) : 1024 - 1032
12345